Search

Search Constraints

You searched for: Author/Creator Holleman, Frits

Search Results

1. Alternative treatments for type 2 diabetes and associated metabolic diseases: medical therapy or endoscopic duodenal mucosal remodelling?. Issue 11 (8th September 2021)

4. Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time. Issue 3 (30th May 2019)

5. Durable metabolic improvements 2 years after duodenal mucosal resurfacing (DMR) in patients with type 2 diabetes (REVITA-1 Study). (February 2022)

6. Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study. Issue 2 (22nd July 2019)

8. Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial. Issue 1 (26th October 2020)

9. Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial. Issue 1 (26th October 2020)